Showing results (51-60 of 57) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Brain : a Journal of Neurology|October 6, 2025
Reference proteins to improve Core 1 and Core 2 Alzheimer's disease CSF and plasma biomarkersLinda Karlsson, Shorena Janelidze, Nicolas R Barthélemy, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersLinda Karlsson, Shorena Janelidze, Nicolas R Barthélemy, et al.Nature Communications|January 29, 2025
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatmentKatharina Bolsewig, Eline A J Willemse, Pascual Sánchez-Juan, et al.Nature Medicine|February 16, 2026
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disordersKatharina Bolsewig, Giovanni Bellomo, Yanaika S Hok-A-Hin, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2025
Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center studyJames D Doecke, Giovanni Bellomo, Lisa Vermunt, et al.Nature Aging|July 20, 2026
Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementiasGiovanni Bellomo, Lisa Vermunt, Sjors In 't Veld, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2021
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overviewConstance Delaby, Charlotte E Teunissen, Kaj Blennow, et al.Pageof 6